Class II · Moderate risk Terminated
Cefdinir for Oral Suspension USP
Reason Defective container: lack of seal integrity.
Cefdinir for Oral Suspension
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
What was recalled
Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.
- Recalling firm
- Teva Pharmaceuticals USA, Inc.
- NDC code
- 0093-4136-64
- Origin
- PA, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-247-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Cefdinir recalls
See all
Class II · Moderate risk Terminated
Cefdinir for Oral Suspension USP 125 mg/5 mL
Reason Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Class II · Moderate risk Terminated
Cefdinir for Oral Suspension USP 250 mg/5 mL
Reason Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Class II · Moderate risk Terminated
Cefdinir for Oral Suspension USP
Reason Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.
Class III · Low risk Terminated
Cefdinir for Oral Suspension USP
Reason Presence of Foreign substance: identified as a dead ant.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.